DanielAGrafMDFACNS

Neurology • Norfolk, VA

Epilepsy

Director of Neurophysiology

Join to view full profile

Dr. Graf is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Graf's full profile

Already have an account?

Office
301 Riverview Ave
Ste 202A
Norfolk, VA 23510
Phone+1 757-252-9015

Fax+1 757-510-9041

Education & Training

Emory University School of MedicineFellowship, Neurology, 2017 - 2018
University of Texas Medical Branch HospitalsResidency, Neurology, 2014 - 2017
University at BuffaloResidency, Nuclear Medicine, 2011 - 2013
Bridgeport Hospital/Yale UniversityResidency, Radiology-Diagnostic, 2009 - 2010
Maimonides Medical CenterInternship, Internal Medicine, 2008 - 2009
St. George's University School of MedicineClass of 2008

Certifications & Licensure

VA State Medical License 2021 - 2026
NC State Medical License 2022 - 2025
PA State Medical License 2018 - 2022
GA State Medical License 2017 - 2018
American Board of Nuclear Medicine Nuclear Medicine
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Epilepsy

Publications & Presentations

PubMed

6 citations
A journey into the unknown: An ethnographic examination of drug-resistant epilepsy treatment and management in the United States
Glenn D.R. Watson, Pegah Afra, Luca Bartolini, Daniel A. Graf, Sanjeev V. Kothare
Epilepsy & Behavior. 2021-09-23
3 citations
Preoperative assessment of malignant potential of gastrointestinal stromal tumor by dual-time-point 18F-fluorodeoxyglucose positron emission tomography imaging: Useful...
Yeongkeun Kwon, Eunkyung Park, Kisoo Pahk, Sungeun Kim, Min Ju Kim
Journal of Cancer Research and Therapeutics. 2018-01-01
13 citations
18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab.
Dominick Lamonica, Daniel A. Graf, Mihaela C. Munteanu, Myron S. Czuczman
Journal of Nuclear Medicine. 2017-01-01

Press Mentions

Craniofacial Development: Neural Crest in Molecular EmbryologyMarch 15th, 2021